Cost-effective strategies to screen for left ventricular systolic dysfunction in the community--a concept

Area of Science:

• Cardiology
• Medical Technology
• Health Economics

Background:

• Left ventricular systolic dysfunction (LVSD) is a primary cause of heart failure, necessitating early detection and intervention to slow disease progression.
• Traditional echocardiography is the gold standard for LVSD assessment, but newer, cost-effective bedside techniques are emerging.
• Existing diagnostic tools include electrocardiography and serum brain natriuretic peptide, which also show predictive value for LVSD.

Purpose of the Study:

• To review the pros and cons of various investigative strategies for screening subjects for LVSD.
• To discuss the likely cost-effectiveness of different screening approaches.
• To address the major question of the most cost-effective strategy for LVSD screening.

Main Methods:

• Review of existing literature on echocardiography, electrocardiography, and serum brain natriuretic peptide for LVSD detection.
• Analysis of preliminary data on the predictive accuracy and cost-effectiveness of hand-held echocardiography systems.
• Comparative discussion of traditional versus newer, bedside screening techniques.

Main Results:

• Hand-held echocardiography systems demonstrate high predictive accuracy for LVSD assessment.
• Bedside techniques offer a potentially more cost-effective alternative to traditional echocardiography.
• Systematic studies on the cost-effectiveness of various LVSD screening strategies are limited but emerging.

Conclusions:

• The optimal cost-effective strategy for LVSD screening requires further systematic investigation.
• Emerging bedside technologies present promising alternatives for early heart failure detection.
• Balancing diagnostic accuracy with economic efficiency is key for widespread LVSD screening.